An assessment of selected immune parameters of patients with Hodgkin's disease
- Authors:
- Andrzej Kołtan
- Sylwia Kołtan
- Robert Dębski
- Elżbieta Grześk
- Mariusz Wysocki
- Grzegorz Grześk
View Affiliations
Affiliations: Department of Pediatrics, Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz 85‑094, Poland, Department of Pediatrics, Hematology and Oncology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz 85‑094, Poland, Department of Pharmacology and Therapeutics, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Toruń, Bydgoszcz 85‑094, Poland
- Published online on: September 19, 2014 https://doi.org/10.3892/mco.2014.421
-
Pages:
237-243
Metrics: Total
Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
This article is mentioned in:
Abstract
Malignancy and oncologic treatment lead to various secondary immune disorders. In particular, little is known regarding immune reconstitution following cancer therapy. Lymphocytes, their subpopulations and immunoglobulin serum concentrations were assessed in patients with Hodgkin's disease at diagnosis (group I, 26 patients), cessation of therapy (group II, 21 patients) and 2 years after treatment (group III, 18 patients). Absolute lymphocyte count was significantly decreased in group II only (15/21 vs. 6/26 and 0/18 patients). In group I, the absolute count of the following subsets were decreased: Cluster of differentiation 19+ (CD19+) (18/26 patients), CD3+ (13/26), CD3+CD4+ (11/26) and CD3+CD8+ (7/26). In group II, the reduction of CD19+, CD3+ and CD3+CD4+ cell counts was evident (12/21, 16/21 and 19/21 patients, respectively), with the CD3+CD4+/CD3+CD8+ ratio distinctly lowered in the majority of patients (16/21). Similar changes in the percentages of lymphocyte subsets were observed. In the majority of patients in group III, the percentage of lymphocyte subsets were normal, but absolute lymphocyte counts were elevated (CD19+ in 11/18, CD3+ in 12/18, CD3+CD4+ in 13/18 and CD3+CD8+ in 11/18 patients). In half the patients at diagnosis, immunoglobulin G (IgG) was significantly elevated. In conclusion, disorders assessed in the percentage distribution and individual subpopulations of lymphocytes was applicable mainly to patients at the time of the diagnosis and shortly following completion of treatment. The analysis of time‑distant consequences showed disorders only in the content of the percentage of CD4+ memory cells. The concentration of IgG at the time of diagnosis was significantly elevated in half the patients, which is possibly associated with the pathogenesis of the disease. The treatment does not appear to noticeably affect the production of IgG, IgA and IgM.
View References
|
1
|
Dayer-Pastore F, McClain KL and Shearer
WT: Secondary immunodeficiencies due to proliferative and
histiocytic disordersImmunologic Disorders in Infants and Children.
Stiehm ER, Ochs HD and Winkelstein JA: 5th. W.B. Saunders;
Philadelphia, PA: pp. 835–857. 2004
|
|
2
|
Olweny CL: Cotswolds modification of the
Ann Arbor staging system for Hodgkin's disease. J Clin Oncol.
8:15981990.
|
|
3
|
Comans-Bitter WM, de Groot R, van den
Beemd R, et al: Immunophenotyping of blood lymphocytes in
childhood. Reference values for lymphocyte subpopulations. J
Pediatr. 130:388–393. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Zeman K, Fornalczyk-Wachowska E, Pokoca L,
et al: Percentual composition of basic lymphocyte subpopulations
and NK cells in Polish popoulation. Cent Europ J Immunol. 21 Suppl
2:107–113. 1996.(In Polish).
|
|
5
|
Grześk E, Kołtan S, Dębski R, et al:
Concentrations of IL-15, IL-18, IFN-γ and activity of
CD4+, CD8+ and NK cells at admission in
children with viral bronchiolitis. Exp Ther Med. 1:873–877.
2010.
|
|
6
|
Dębski R, Wysocki M, Kołtan S, et al: An
assessment of lymphocyte B, T and NK subsets in peripheral blood
and serum immunoglobulin concentrations in children with acute
lymphoblastic leukemia and Hodgkin's disease at diagnosis. Pediatr
Pol. 80:354–359. 2005.
|
|
7
|
Dębski R, Wysocki M, Kurylak A, et al:
Evaluation of lymphocyte B, T and NK subsets in peripheral blood
and serum immunoglobulin concentrations in children with acute
lymphoblastic leukemia and Hodgkin's disease after oncological
treatment. Przeg Pediatr. 35:131–136. 2005.(In Polish).
|
|
8
|
Eckschlager T, Průsa R, Hladíková M, et
al: Lymphocyte subpopulations and immunoglobulin levels in
Hodgkin's disease survivors. Neoplasma. 51:261–264. 2004.
|
|
9
|
Macklis RM, Mauch PM, Burakoff SJ and
Smith BR: Lymphoid irradiation results in long-term increases in
natural killer cells in patients treated for Hodgkin's disease.
Cancer. 69:778–783. 1992.PubMed/NCBI
|
|
10
|
Alanko S, Pelliniemi TT and Salmi TT:
Recovery of blood lymphocytes and serum immunoglobulins after
treatment of solid tumors in children. Pediatr Hematol Oncol.
11:33–45. 1994. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
van Tilburg CM, van Gent R, Bierings MB,
et al: Immune reconstitution in children following chemotherapy for
haematological malignancies: a long-term follow-up. Br J Haematol.
152:201–210. 2011.PubMed/NCBI
|
|
12
|
Watanabe N, De Rosa SC, Cmelak A, et al:
Long-term depletion of naive T cells in patients treated for
Hodgkin's disease. Blood. 90:3662–3672. 1997.PubMed/NCBI
|
|
13
|
Tan CT, De Sousa M and Good RA:
Distinguishing features of the immunology of Hodgkin's disease in
children. Cancer Treat Rep. 66:969–975. 1982.
|
|
14
|
Bernatowska E: Prophylaxis of infectious
diseases in immune deficiencies. Standardy Medyczne. 34:4–42.
2008.(In Polish).
|
|
15
|
Kołtan S, Kołtan A, Grześk E, et al:
Analysis of the immunological reconstitution, effectiveness and
safety of vaccination in children with cancer. Przegl Epidemiol.
64:537–542. 2010.(In Polish).
|
|
16
|
Rubin LG, Levin MJ, Ljungman P, et al:
2013 IDSA clinical practice guideline for vaccination of the
immunocompromised host. Clin Infect Dis. 58:e44–e100
|
